Skip to main content

Walleye Capital LLC

Position in AMLX — Amylyx Pharmaceuticals, Inc.

CIK 1758720 NEW YORK, NY

Position in AMLX

as of Mar 31, 2026 · filed May 13, 2026
Position Value
$857,782
+$788,443 QoQ
Shares Held
61,711
+975.1% QoQ
Ownership
0.056%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2022
14 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in AMLX Over Time

Shares Held

Position Value (USD)

Derivatives in AMLX

reported options exposure · as of Mar 31, 2026
CallValue
$87,570
CallShares
6,300
PutValue
$25,020
PutShares
1,800

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Mar 31, 2026

Walleye Capital LLC holds $49,633,459 across 26 Drug Manufacturers - Specialty & Generic names. AMLX ranks #11 (1.7% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in AMLX

Export CSV
29 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $857,782 61,711
2026-03-31 $87,570 6,300
2026-03-31 $25,020 1,800
2025-12-31 $107,512 8,900
2025-12-31 $69,339 5,740
2025-12-31 $381,728 31,600
2025-09-30 $301,698 22,200
2025-09-30 $92,412 6,800
2025-03-31 $888,143 250,888
2024-12-31 $126,630 33,500
2024-12-31 $86,940 23,000
2024-12-31 $1,961,003 518,784
2024-09-30 $2,172,724 670,594
2024-06-30 $117,268 61,720
2024-03-31 $1,027,710 361,870
2024-03-31 $20,732 7,300
2024-03-31 $284 100
2023-12-31 $292,928 19,900
2023-12-31 $8,577,756 582,728
2023-09-30 $459,581 25,100
2023-09-30 $1,848,559 100,959
2023-09-30 $32,958 1,800
2023-06-30 $1,129,793 52,378
2023-06-30 $293,352 13,600
2022-12-31 $646,329 17,492
2022-12-31 $247,565 6,700
2022-12-31 $107,155 2,900
2022-09-30 $1,741,978 61,882
2022-03-31 $362,202 28,187